Jackson Laboratory

The Bar Harbor, Maine-based nonprofit has exceeded the hiring targets tied to nearly $290 million in state support for its Farmington genomic medicine facility, but Connecticut has yet to receive any royalty payments and direct startup creation has been limited to two spinouts.

With scientific researchers learning more about editing human genes to treat rare diseases, a new form of medical treatment has arrived and a new process for approving those treatments is on the horizon.

The Jackson Laboratory, a Maine-based nonprofit biomedical research institution with a major hub in Farmington, recently announced it has completed its acquisition of the New York Stem Cell Foundation (NYSCF), a nonprofit dedicated to advancing cures through stem cell research. 

A Farmington-based bioscience startup is hoping its technology can help with the early detection of newborn illnesses, saving lives and possibly billions of dollars in spending on healthcare services.

The Jackson Laboratory for Genomic Medicine in Farmington has announced that scientist Eric Wang has joined the...

The Jackson Laboratory, a Maine-based nonprofit biomedical research institution with a major hub in Farmington, said that...

With an eye toward possible expansion of The Jackson Laboratory for Genomic Medicine in Farmington, new spinoffs...

Jackson Laboratory (JAX), a Maine-based nonprofit biomedical research institution with a location in Farmington, appointed human genetics...

Jackson Laboratory for Genomic Medicine (JAX), which has a major Farmington presence, is scaling up production of research mice designed to help scientists around the world develop vaccines and treatments for COVID-19.

Farmington’s Jackson Laboratory for Genomic Medicine (JAX) research center is teaming with a national nonprofit health system to advance treatment options for children suffering from genetic orthopaedic conditions.